The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Isoprostanes: markers and mediators of oxidative stress
Abstract
Some years ago it was discovered that prostaglandin F 2 ‐like compounds are formed in vivo by nonenzymatic free radical‐catalyzed peroxidation of arachidonic acid. Because these compounds are a series of isomers that contain the prostane ring of prostaglandins, they were termed F 2 ‐isoprostanes. Intermediates in the isoprostane pathway are prostaglandin H 2 ‐like compounds that become reduced to form F 2 ‐isoprostanes but also undergo rearrangement in vivo to form E 2 ‐, D 2 ‐, A 2 ‐, J 2 ‐isoprostanes, isothromboxanes, and highly reactive γ ‐ketoaldehydes, termed isoketals. Analogous compounds have also been shown to be formed from free radical mediated oxidation of docosoahexaenoic acid. Because docosahexaenoic acid is highly enriched in neurons, these compounds have been termed neuroprostanes and neuroketals. An important aspect of the discovery of isoprostanes is that measurement of F 2 ‐isoprostanes has emerged as one of the most reliable approaches to assess oxidative stress status in vivo, providing an important tool to explore the role of oxidative stress in the pathogenesis of human disease. Measurement of F 4 ‐neuroprostanes has also proved of value in exploring the role of oxidative stress in neurodegenerative diseases. Products of the isoprostane pathway have been found to exert potent biological actions and therefore may participate as physiological mediators of disease.—Montuschi, P., Barnes, P. J., Roberts, L J., II. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 18, 1791‐1800 (2004 )
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,899
Self-citationMorrow, J. D., Frei, B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W. E., Oates, J. A., & Roberts, L. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321804 · Cited by 1,339
Self-citationKeaney, J. F., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., & Benjamin, E. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000058402.34138.11 · Cited by 1,304
The measurement and mechanism of lipid peroxidation in biological systems
Gutteridge, J. M. C., & Halliwell, B. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90206-q · Cited by 1,283
Measurement of F2-isoprostanes as an index of oxidative stress in vivo
Roberts, L. J., & Morrow, J. D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00264-6 · Cited by 996
Self-citationDavı̀, G., Ciabattoni, G., Consoli, A., Mezzetti, A., Falco, A., Santarone, S., Pennese, E., Vitacolonna, E., Bucciarelli, T., Costantini, F., et al. (1999) · Circulation · doi:10.1161/01.cir.99.2.224 · Cited by 742
Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
Morrow, J. D., Awad, J. A., Boss, H. J., Blair, I. A., & Roberts, L. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10721 · Cited by 735
Self-citationModulation of Oxidant Stress In Vivo in Chronic Cigarette Smokers
Reilly, M., Delanty, N., Lawson, J. A., & FitzGerald, G. A. (1996) · Circulation · doi:10.1161/01.cir.94.1.19 · Cited by 612
Praticò, D., Clark, C. M., Liun, F., Lee, V. Y.-M., & Trojanowski, J. Q. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.972 · Cited by 584
The isoprostanes: Unique bioactive products of lipid peroxidation
Morrow, J. D., & Roberts, L. J. (1997) · Progress in Lipid Research · doi:10.1016/s0163-7827(97)00001-5 · Cited by 557
Self-citationIncreased 8-Isoprostane, a Marker of Oxidative Stress, in Exhaled Condensate of Asthma Patients
MONTUSCHI, P., CORRADI, M., CIABATTONI, G., NIGHTINGALE, J., KHARITONOV, S. A., & BARNES, P. J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.1.9809140 · Cited by 551
Self-citationMONTUSCHI, P., COLLINS, J. V., CIABATTONI, G., LAZZERI, N., CORRADI, M., KHARITONOV, S. A., & BARNES, P. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.2001063 · Cited by 548
Self-citationAssociation between Oxidative Stress and Bone Mineral Density
Basu, S., Michaëlsson, K., Olofsson, H., Johansson, S., & Melhus, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5747 · Cited by 522
Takahashi, K., Nammour, T. M., Fukunaga, M., Ebert, J., Morrow, J. D., Roberts, L. J., Hoover, R. L., & Badr, K. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115826 · Cited by 511
Self-citationPryor, W. A., Stanley, J. P., & Blair, E. (1976) · Lipids · doi:10.1007/bf02532843 · Cited by 503
Praticò, D., Tangirala, R. K., Rader, D. J., Rokach, J., & FitzGerald, G. A. (1998) · Nature Medicine · doi:10.1038/2685 · Cited by 501
A new recommended dietary allowance of vitamin C for healthy young women
Levine, M., Wang, Y., Padayatty, S. J., & Morrow, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171318198 · Cited by 496 · cited 1×
“Moreover, a high dose of vitamin C (2500 mg/day) had no effect on lowering F2-isoprostane levels in normal subjects (90) but was found to be effective in suppressing isoprostane formation in smokers (50).”
BackgroundIsoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease
Patrono, C., & FitzGerald, G. A. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2309 · Cited by 453 · cited 3×
“F2-Isoprostanes promote platelet activation (70) and induce mitogenesis in vascular smooth muscle cells (61).”
BackgroundMallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J., & Tedgui, A. (1998) · Circulation · doi:10.1161/01.cir.97.16.1536 · Cited by 453
Montine, T. J., Neely, M. D., Quinn, J. F., Beal, M. F., Markesbery, W. R., Roberts, L. J., & Morrow, J. D. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00807-9 · Cited by 449
Self-citationFormation of Isoprostane-like Compounds (Neuroprostanes) in Vivo from Docosahexaenoic Acid
Roberts, L. J., Montine, T. J., Markesbery, W. R., Tapper, A. R., Hardy, P., Chemtob, S., Dettbarn, W. D., & Morrow, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13605 · Cited by 418
Self-citationIncreased F 2 ‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo
Pratico, D., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & Fitzgerald, G. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1777 · Cited by 405
Greater Oxidative Stress in Healthy Young Men Compared With Premenopausal Women
Ide, T., Tsutsui, H., Ohashi, N., Hayashidani, S., Suematsu, N., Tsuchihashi, M., Tamai, H., & Takeshita, A. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.104515 · Cited by 356
In Vivo Formation of 8-Epi-Prostaglandin F2αIs Increased in Hypercholesterolemia
Davi, G., Alessandrini, P., Mezzetti, A., Minotti, G., Bucciarelli, T., Costantini, F., Cipollone, F., Bon, G. B., Ciabattoni, G., & Patrono, C. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.3230 · Cited by 350
Pratic�, D., Clark, C. M., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & FitzGerald, G. A. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<809::aid-ana19>3.0.co;2-9 · Cited by 348
Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
Praticò, D., Iuliano, L., Mauriello, A., Spagnoli, L., Lawson, J. A., Rokach, J., Maclouf, J., Violi, F., & FitzGerald, G. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119735 · Cited by 344
Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?
Halliwell, B. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00097-3 · Cited by 343
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
Wang, Z., Ciabattoni, G., Créminon, C., Lawson, J., Fitzgerald, G. A., Patrono, C., & Maclouf, J. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12087-9 · Cited by 341
Cracowski, J.-L., Durand, T., & Bessard, G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02053-9 · Cited by 330
The measurement of free radical reactions in humans: Some thoughts for future experimentation
Halliwell, B., & Grootveld, M. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81455-2 · Cited by 320
Moore, K. P., Holt, S. G., Patel, R. P., Svistunenko, D. A., Zackert, W., Goodier, D., Reeder, B. J., Clozel, M., Anand, R., Cooper, C. E., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.31731 · Cited by 278
Self-citationIncreased Formation of Distinct F2Isoprostanes in Hypercholesterolemia
Reilly, M. P., Praticò, D., Delanty, N., DiMinno, G., Tremoli, E., Rader, D., Kapoor, S., Rokach, J., Lawson, J., & FitzGerald, G. A. (1998) · Circulation · doi:10.1161/01.cir.98.25.2822 · Cited by 271
Effects of Vitamin E on Lipid Peroxidation in Healthy Persons
Meagher, E. A. (2001) · JAMA · doi:10.1001/jama.285.9.1178 · Cited by 270
Delanty, N., Reilly, M. P., Pratico, D., Lawson, J. A., McCarthy, J. F., Wood, A. E., Ohnishi, S. T., Fitzgerald, D. J., & FitzGerald, G. A. (1997) · Circulation · doi:10.1161/01.cir.95.11.2492 · Cited by 267
8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung Diseases
MONTUSCHI, P., TONI, G. C., PAREDI, P., PANTELIDIS, P., du BOIS, R. M., KHARITONOV, S. A., & BARNES, P. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9803102 · Cited by 267
Self-citationCylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2α
Pratico, D., Lawson, J. A., & FitzGerald, G. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9800 · Cited by 264
PRATICÒ, D., BASILI, S., VIERI, M., CORDOVA, C., VIOLI, F., & FITZGERALD, G. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.6.9709066 · Cited by 255
Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells
Fukunaga, M., Makita, N., Roberts, L. J., Morrow, J. D., Takahashi, K., & Badr, K. F. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.6.c1619 · Cited by 254
Self-citationMcAdam, B. F., Mardini, I. A., Habib, A., Burke, A., Lawson, J. A., Kapoor, S., & FitzGerald, G. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9523 · Cited by 253
Alcohol-induced generation of lipid peroxidation products in humans
Meagher, E. A., Barry, O. P., Burke, A., Lucey, M. R., Lawson, J. A., Rokach, J., & FitzGerald, G. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5584 · Cited by 252
Increased CSF F 2 -isoprostane concentration in probable AD
Montine, T. J., Beal, M. F., Cudkowicz, M. E., O’Donnell, H., Margolin, R. A., McFarland, L., Bachrach, A. F., Zackert, W. E., Roberts, L. J., & Morrow, J. D. (1999) · Neurology · doi:10.1212/wnl.52.3.562 · Cited by 251
Self-citationLynch, S. M., Morrow, J. D., Roberts, L. J., & Frei, B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117107 · Cited by 236
Self-citationExhaled Breath Condensate Isoprostanes Are Elevated in Patients With Acute Lung Injury or ARDS
Carpenter, C. T., Price, P. V., & Christman, B. W. (1998) · Chest · doi:10.1378/chest.114.6.1653 · Cited by 233
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
Janssen, L. J. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.6.l1067 · Cited by 224
IPF 2α -I: An index of lipid peroxidation in humans
Praticò, D., Barry, O. P., Lawson, J. A., Adiyaman, M., Hwang, S.-W., Khanapure, S. P., Iuliano, L., Rokach, J., & FitzGerald, G. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3449 · Cited by 219
Fessel, J. P., Porter, N. A., Moore, K. P., Sheller, J. R., & Roberts, L. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252649099 · Cited by 219
Self-citationMorrow, J. D., Minton, T. A., & Roberts, L. J. (1992) · Prostaglandins · doi:10.1016/0090-6980(92)90077-7 · Cited by 215
Self-citationExhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis
Montuschi, P. (2000) · Thorax · doi:10.1136/thorax.55.3.205 · Cited by 214
Self-citationMinuz, P., Patrignani, P., Gaino, S., Degan, M., Menapace, L., Tommasoli, R., Seta, F., Capone, M. L., Tacconelli, S., Palatresi, S., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039528.49161.e9 · Cited by 212
Reilly, M. P., Delanty, N., Roy, L., Rokach, J., Callaghan, P. O., Crean, P., Lawson, J. A., & FitzGerald, G. A. (1997) · Circulation · doi:10.1161/01.cir.96.10.3314 · Cited by 210
Gay, C. A., & Gebicki, J. M. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00606-1 · Cited by 199
A nomenclature system for the isoprostanes
Taber, D. F., Morrow, J. D., & Jackson Roberts, L. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00005-1 · Cited by 194
Audoly, L. P., Rocca, B., Fabre, J.-E., Koller, B. H., Thomas, D., Loeb, A. L., Coffman, T. M., & FitzGerald, G. A. (2000) · Circulation · doi:10.1161/01.cir.101.24.2833 · Cited by 193
The isoprostanes in biology and medicine
Praticò, D. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00411-8 · Cited by 188
Analysis of exhaled breath condensate for monitoring airway inflammation
Montuschi, P., & Barnes, P. J. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02020-5 · Cited by 187
Self-citationGeneration of 8-Epiprostaglandin F by Human Monocytes
Praticó, D., & FitzGerald, G. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8919 · Cited by 187
Reich, E. E., Markesbery, W. R., Roberts, L. J., Swift, L. L., Morrow, J. D., & Montine, T. J. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63968-5 · Cited by 183
Self-citationProudfoot, J., Barden, A., Mori, T. A., Burke, V., Croft, K. D., Beilin, L. J., & Puddey, I. B. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4187 · Cited by 175
Brame, C. J., Salomon, R. G., Morrow, J. D., & Roberts, L. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13139 · Cited by 172
Self-citationEvidence of free radical–mediated injury (isoprostane overproduction) in scleroderma
Stein, C. M., Tanner, S. B., Awad, J. A., Roberts, L. J., & Morrow, J. D. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390711 · Cited by 160
Self-citationRoberts, L. J., Moore, K. P., Zackert, W. E., Oates, J. A., & Morrow, J. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20617 · Cited by 156
Self-citationYura, T., Fukunaga, M., Khan, R., Nassar, G., Badr, K. F., & Montero, A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00596.x · Cited by 155
Formation of Reactive Cyclopentenone Compounds in Vivo as Products of the Isoprostane Pathway
Chen, Y., Morrow, J. D., & Roberts, L. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10863 · Cited by 155
Self-citationDietrich, M., Block, G., Hudes, M. L., Morrow, J. D., Norkus, E. P., Traber, M. G., Cross, C. E., & Packer, L. (2002) · PubMed · Cited by 146
Oxidative Stress and Platelet Activation in Homozygous Homocystinuria
Davì, G., Minno, G. D., Coppola, A., Andria, G., Cerbone, A. M., Madonna, P., Tufano, A., Falco, A., Marchesani, P., Ciabattoni, G., et al. (2001) · Circulation · doi:10.1161/hc3501.095287 · Cited by 140
Increased lipid peroxidation in patients with rhabdomyolysis
Holt, S., Reeder, B. J., Wilson, M., Harvey, S. E., Morrow, J. D., Roberts, L. J., & Moore, K. P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05768-7 · Cited by 135
Self-citationAutoxidation of Polyunsaturated Fatty Acids
Pryor, W. A., Stanley, J. P., Blair, E., et al. (1976) · Archives of Environmental Health An International Journal · doi:10.1080/00039896.1976.10667220 · Cited by 134
8-Epi-PGF2 Alpha, a Novel Noncyclooxygenase-Derived Prostaglandin, Constricts Airways in Vitro
Kawiková, I., Barnes, P. J., Takahashi, T., Tadjkarimi, S., Yacoub, M. H., & Belvisi, M. G. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564103 · Cited by 133
Self-citationA novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2αon retinal vessels
Lahaie, I., Hardy, P., Hou, X., et al. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.5.r1406 · Cited by 129
Urinary isoprostane excretion is not confounded by the lipid content of the diet
Richelle, M., Turini, M. E., Guidoux, R., Tavazzi, I., Métairon, S., & Fay, L. B. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01259-4 · Cited by 127
The use of antioxidant supplements in coronary heart disease
Kritharides, L., & Stocker, R. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00011-4 · Cited by 123
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients
Ikizler, T. A., Morrow, J. D., Roberts, L. J., Evanson, J. A., Becker, B. N., Hakim, R. M., Shyr, Y., & Himmelfarb, J. (2002) · Clinical Nephrology · doi:10.5414/cnp58190 · Cited by 122
Self-citationKunapuli, P., Lawson, J. A., Rokach, J., Meinkoth, J. L., & FitzGerald, G. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22442 · Cited by 119
Vassalle, C., Botto, N., Andreassi, M. G., Berti, S. L., & Biagini, A. (2003) · Coronary Artery Disease · doi:10.1097/01.mca.0000063504.13456.c3 · Cited by 117
Montine, T. J., Markesbery, W. R., Zackert, W. E., Sanchez, S. C., Roberts, L. J., & Morrow, J. D. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65185-1 · Cited by 115
Self-citationBachi, A., Zuccato, E., Baraldi, M., Fanelli, R., & Chiabrando, C. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02087-x · Cited by 114
Davies, S. S., Amarnath, V., Montine, K. S., Bernoud‐Hubac, N., Boutaud, O. G., Montine, T. J., & Roberts, L. J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0696fje · Cited by 108
Self-citationGreco, A., Minghetti, L., & Levi, G. (2000) · Neurochemical Research · doi:10.1023/a:1007608615682 · Cited by 103
Cerebrospinal fluid F 2 -isoprostanes are elevated in Huntington’s disease
Montine, T. J., Beal, M. F., Robertson, D., Cudkowicz, M., Biaggioni, I., O’Donnell, H., Zackert, W. E., Roberts, L. J., & Morrow, J. D. (1999) · Neurology · doi:10.1212/wnl.52.5.1104 · Cited by 103
Self-citationFunctional Characterization of the Ocular Prostaglandin F2α (PGF2α) Receptor
Kunapuli, P., Lawson, J. A., Rokach, J., & FitzGerald, G. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27147 · Cited by 102
In Vivo Lipid Peroxidation and Platelet Activation in Cystic Fibrosis
Ciabattoni, G., Davì, G., Collura, M., Iapichino, L., Pardo, F., Ganci, A., Romagnoli, R., Maclouf, J., & Patrono, C. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9911071 · Cited by 99
Enhanced Lipid Peroxidation in Hepatic Cirrhosis
Praticò, D., Iuliano, L., Basili, S., Ferro, D., Camastra, C., Cordova, C., FitzGerald, G. A., & Violi, F. (1998) · Journal of Investigative Medicine · doi:10.1177/108155899804600209 · Cited by 97
Formation of Highly Reactive γ-Ketoaldehydes (Neuroketals) as Products of the Neuroprostane Pathway
Bernoud‐Hubac, N., Davies, S. S., Boutaud, O. G., Montine, T. J., & Roberts, L. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103768200 · Cited by 94
Self-citationFam, S. S., Murphey, L. J., Terry, E. S., Zackert, W. E., Chen, Y., Gao, L., Pandalai, S., Milne, G. L., Roberts, L. J., Porter, N. A., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205638200 · Cited by 92
Self-citationGopaul, N. K., Halliwell, B. B., & Änggård, E. (2000) · Free Radical Research · doi:10.1080/10715760000300671 · Cited by 89
Klein, T., Reutter, F., Schweer, H., et al. (1997) · PubMed · Cited by 85
Nonaka‐Sarukawa, M., Yamamoto, K., Aoki, H., Takano, H., Katsuki, T., Ikeda, U., & Shimada, K. (2003) · Heart · doi:10.1136/heart.89.8.871 · Cited by 83
Evaluation of the postprandial effects of a fast-food meal on human plasma F2-isoprostane levels
Gopaul, N. K., Zacharowski, K. D., Halliwell, B. B., & Änggård, E. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00167-2 · Cited by 79
Indirect monitoring of lung inflammation
Montuschi, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd751 · Cited by 76
Self-citationJanssen, L. J., & Tazzeo, T. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1060 · Cited by 71
Pratic, D., Iuliano, L., Amerio, G., Tang, L. X., Rokach, J., Sabatino, G., & Violi, F. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<795::aid-ana15>3.0.co;2-# · Cited by 69
Cyclooxygenase‐Dependent Formation of the Isoprostane 8‐EPI Prostaglandin F2αa
Praticò, D., Lawson, J. A., & FitzGerald, G. A. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb52730.x · Cited by 66
8-Epi-PGF2alpha Induces Airflow Obstruction and Airway Plasma Exudation In Vivo
Okazawa, A., Kawiková, I., Cui, Z., et al. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032175 · Cited by 65
Antioxidant Therapy and Atherosclerosis Animal and Human Studies
Meagher, E. A., & Rader, D. J. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00105-0 · Cited by 64
Anaphylaxis increases 8-iso-prostaglandin F2α release from guinea-pig lung in vitro
Montuschi, P., Currò, D., Ragazzoni∘, E., Preziosi, P., & Ciabattoni, G. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00859-0 · Cited by 60
Self-citationIncreased urinary F2-isoprostanes in patients with Crohn's disease
Cracowski, J., Bonaz, B. L., Bessard, G., Bessard, J., Anglade, C., & Fournet, J. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05427.x · Cited by 50
Helmersson, J., & Basu, S. (2001) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0295 · Cited by 49
Is Pentane a Normal Constituent of Human Breath?
Cailleux, A., & Allain, P. (1993) · Free Radical Research Communications · doi:10.3109/10715769309147499 · Cited by 47
Generation of the Isoprostane 8-Epi-prostaglandin F2α In Vitro and In Vivo via the Cyclooxygenases
Klein, T., Reutter, F., Schweer, H., Seyberth, H. W., & Nüsing, R. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36968-x · Cited by 43
A prospective analysis of oxidative stress and liver transplantation1
Burke, A., FitzGerald, G. A., & Lucey, M. R. (2002) · Transplantation · doi:10.1097/00007890-200207270-00012 · Cited by 36
Fontana, L., Giagulli, C., Cominacini, L., Pasini, A. F., Minuz, P., Lechi, A., Sala, A., & Laudanna, C. (2002) · Circulation · doi:10.1161/01.cir.0000037223.92135.38 · Cited by 26
Cited by
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Kurutas, E. B. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0186-5 · Cited by 2,152
Biomarkers of Oxidative Damage in Human Disease
Dalle-Donne, I., Rossi, R., Colombo, R., Giustarini, D., & Milzani, A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.061408 · Cited by 1,703
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
Barnes, P. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.011 · Cited by 1,683
Self-citationThe effects of oxidative stress on female reproduction: a review
Agarwal, A., Aponte-Mellado, A., Premkumar, B. J., Shaman, A., & Gupta, S. (2012) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-10-49 · Cited by 1,637
Metadata
- Authors
- Montuschi, P., Barnes, P. J., & Roberts, L. J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-12
- Volume
- 18
- Issue
- 15
- Pages
- 1791-1800
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2028164957
- Cited by
- 747
- References
- 101
- FWCI
- 13.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.